| 中国高致病性禽流感免疫预防风险评估 |
| |
| 引用本文： | 吴春艳,王靖飞,赵丽丹,李静,吉增涛,杨彦涛,王笑梅,童光志. 中国高致病性禽流感免疫预防风险评估[J]. 畜牧兽医学报, 2006, 37(6): 621-624 |
| |
| 作者姓名： | 吴春艳 王靖飞 赵丽丹 李静 吉增涛 杨彦涛 王笑梅 童光志 |
| |
| 作者单位： | 1. 中国农业科学院哈尔滨兽医研究所,动物疫病诊断与流行病学中心,哈尔滨,150001
2. 中国农业科学院哈尔滨兽医研究所,兽医生物技术国家重点实验室,哈尔滨,150001 |
| |
| 基金项目： | 国家科技攻关计划课题（2004BA519A 25-05） |
| |
| 摘 要： | 疫苗接种是当前我国预防和控制HPAI疫情的有效手段之一.由于影响HPAI免疫预防效果的因素众多,会给免疫预防带来风险.对这些风险因子进行识别,并系统分析其所引起的风险程度的高低,进而采取针对性的风险管理措施,能有效提高免疫预防的效果.本研究首次运用层次分析法（Analytic Hierarchy Process, AHP）构建了HPAI免疫预防风险评估模型,通过确定风险因子权重,依权重大小对风险因子进行排序,确定风险等级.分析结果表明：管理不良、接种操作不规范、实验室监测等是我国免疫预防的高风险因素.通过对免疫预防风险进行综合分析,为HPAI免疫预防管理和决策提供了科学依据.
|
| 关 键 词： | 高致病性禽流感 免疫预防 层次分析法 风险评估 |
| 文章编号： | 0366-6964（2006）06-0621-04 |
| 收稿时间： | 2005-11-21 |
| 修稿时间： | 2005-11-21 |
Risk Assessment of Immune Prevention for Highly Pathogenic Avian Influenza in China |
| |
| WU Chun-yan,WANG Jing-fei,ZHAO Li-dan,LI Jing,JI Zeng-tao,YANG Yan-tao,WANG Xiao-mei,TONG Guang-zhi. Risk Assessment of Immune Prevention for Highly Pathogenic Avian Influenza in China[J]. Chinese Journal of Animal and Veterinary Sciences, 2006, 37(6): 621-624 |
| |
| Authors: | WU Chun-yan WANG Jing-fei ZHAO Li-dan LI Jing JI Zeng-tao YANG Yan-tao WANG Xiao-mei TONG Guang-zhi |
| |
| Affiliation: | 1. Center for Diagnosis and Epidemiology of Animal Infectious Diseases, Harbin Veterinary Research institute, Chinese Academy of Agricultural Sciences, Harbin 150001, China ; 2. National Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150001, China |
| |
| Abstract: | Vaccination is one of effective ways in prevention and controlling the epidemic of HPAI in China. Many risk factors may affect the immune effect in chicken and bring risks to the immune prevention strategies. To identify those risk factors and assess the related risks, we have designed a risk assessment model of immune prevention of HPAI based on the principle of analytic hierarchy process. The analysis results from the model showed that ill management, nonstandard vaccination and laboratory surveillance are high risk factors. The results can provide scientific reference for making surveillance and control measures. |
| |
| Keywords: | HPAI immune prevention analytic hierarchy process risk valuation |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
